Denali: The First Commercial Validation Of The Blood-Brain Barrier Platform
Denali Therapeutics has transitioned from a speculative platform to a commercial-stage rare disease…
seekingalpha.com
OPCH(OPCH)
OPCH
Next earnings: Jul 29, 2026 · Before open
Signal
Leaning Bearish1↑2↓
PRICE
Prev Close
20.33
Open
20.15
Day Range19.74 – 20.38
19.74
20.38
52W Range18.01 – 36.80
18.01
36.80
11% of range
VOLUME & SIZE
Avg Volume
2.1M
FUNDAMENTALS
P/E Ratio
15.7x
EPS (TTM)
—
Div Yield
No dividend
Beta
1.11
Market-like
Performance
1D
-1.48%5D
-29.47%1M
-27.08%3M↓
-42.13%6M
-23.05%YTD
-37.13%1Y
-39.21%Worst: 3M (-42.13%)
Quick Read
Trend—Insufficient MA data
Momentum
NEUTRAL
rev +9% · 18% gross marginValuation
FAIR
P/E 16x vs ~20x sectorHealth
STRONG
CR 1.6 · FCF $1.49/shBullish
Key MetricsTTM
Market Cap$3.13B
Revenue TTM$5.67B
Net Income TTM$206.19M
Free Cash Flow$233.37M
Gross Margin18.0%
Net Margin3.6%
Operating Margin5.9%
Return on Equity15.3%
Return on Assets6.1%
Debt / Equity0.00
Current Ratio1.64
EPS TTM$1.32
Alpha SignalsView Intelligence →
Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Health Radar
3 strong2 watch1 concern
52/100Liquidity
1.64Watch
Leverage
0.00Strong
Coverage
5.5xStrong
ROE
15.3%Strong
ROIC
9.3%Watch
Cash
$233MConcern
ANALYST COVERAGE14 analysts
BUY
▲ +59.8%upside to target
L $26.00
Med $32.00consensus
H $39.00Stock Health
Composite Score
3 of 5 signals bullish
7/10
Technicals
●
✗RSI RangeRSI 46 — Bearish momentum
Volume
●
~Volume FlowNeutral
Fundamentals
●
✓Last EarningsBeat estimates
●
✓Analyst ConsensusBuy
●
✓LiquidityCurrent Ratio 1.64 — healthy liquidity
Upcoming Events
EEarnings Report · After CloseMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
PDividend PaymentAug 10, 2026
In 99 days
FinancialsFull statements →
Technicals
Technical SetupBEARISH
Technicals →Trend
▼ DowntrendGolden Cross · 50D leads 200D by 0.5%
-33.7% vs SMA 50 · -33.3% vs SMA 200
Momentum
RSI45.8Neutral territory
MACD-1.23Below zero — bearish pulse · compressing
Market Position
Price Levels
52W High
$36.80+83.7%
EMA 50
$32.71+63.3%
EMA 200
$31.28+56.2%
Current
$20.03
52W Low
$18.01-10.1%
52-Week RangeNear 52-week low
$18.0111th %ile$36.80
Squeeze SetupVolume-based
No Clear SetupVolume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.
20-Day Money Flow
Acc days:3
Dist days:2
Edge:+1 acc
Volume Context
Avg Vol (50D)1.5M
Recent Vol (5D)
1.2M-20%
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Earnings & Analysts
ANALYST ESTIMATES
Consensus of 9 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $5.6B $5.6B–$5.7B | — | $1.73 | — | ±1% | High7 |
FY2026(current) | $5.9B $5.9B–$6.0B | ▲ +5.3% | $1.87 | ▲ +7.9% | ±2% | High9 |
FY2027 | $6.4B $6.3B–$6.5B | ▲ +8.4% | $2.13 | ▲ +14.3% | ±3% | High9 |
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryOPCH
Last 8Q
+5.4%avg beat
Beat 6 of 8 quarters↑ Estimates rising+11%
Q3'24
—
Q4'24
+6%
Q1'25
+11%
Q2'25
+2%
Q3'25
+5%
Q4'25
—
Q1'26
+8%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Analyst Activity
All ratings →No recent activity
JefferiesHold → Buy
Jan 23
UPGRADE
JefferiesHold
Oct 31
DOWNGRADE
Bank of America Sec…Cautious
Oct 30
DOWNGRADE
Zacks Investment Re…Buy
Apr 26
UPGRADE
Insider Activity
SEC Filings →4 Buys/2 SellsNet Buying
Pate R CarterDir
$971K
Feb 27
SELL
Bavaro MichaelChief Human Re…
$198K
Feb 27
SELL
Kraemer Harry M Jan…Dir
$987K
Nov 3
BUY
Wright Norman L.Dir
$100K
Sep 9
BUY
Pate R CarterDir
$20K
Aug 20
BUY
Kraemer Harry M Jan…Dir
$977K
Aug 20
BUY
Financials
INSTITUTIONAL OWNERSHIP
1
Sumitomo Mitsui Trust Holdings, Inc.
2.6M▲2
Swedbank AB
1.7M—3
Nuveen, LLC
1.6M▲4
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/
1.5M▲5
RIVERBRIDGE PARTNERS LLC
984K▼6
VILLERE ST DENIS J & CO LLC
801K▼7
Leeward Investments, LLC - MA
475K▼8
KORNITZER CAPITAL MANAGEMENT INC /KS
322K▼News & Activity
OPCH News
20 articles · 4h ago
The moon is the ‘ULTIMATE HIGH GROUND': ICON Prime president
youtube.com
What's Going on With Lululemon Stock?
fool.com
What's Going on With UnitedHealth Stock?
fool.com
Great News for Taiwan Semiconductor Stock Investors
fool.com
Why Is Everyone Talking About Netflix Stock?
fool.com
What's Going on With SoFi Stock?
fool.com
Chevron: A Big Timing Issue (Rating Upgrade)
seekingalpha.com
A mammoth economic stimulus passed last year in Germany was meant to jolt the country—and Europe—out of its economic slumber. The problem: Germans just aren't good at spending money.
wsj.com
May The Fourth Be With Palantir (Earnings Preview)
seekingalpha.com
Elektros Ignites a New Era of Profit in Energy: Breakthrough 'Energy Core' Platform Positions Investors to Capture Massive Upside Amid Historic Utility Cost Surge
accessnewswire.com
MNDY DEADLINE ALERT: ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages monday.com Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MNDY
newsfilecorp.com
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Zillow Group, Inc. Investors to Inquire About Securities Class Action Investigation - Z, ZG
newsfilecorp.com
ERC: Improved NAV Health But Not A Buy Yet
seekingalpha.com
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGC
newsfilecorp.com
CWH Deadline: ROSEN, Global Investor Counsel, Encourages Camping World Holdings, Inc. Investors to Secure Counsel Before Important May 11 Deadline in Securities Class Action - CWH
newsfilecorp.com
ROSEN, A RANKED AND LEADING FIRM, Encourages Vital Farms, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - VITL
newsfilecorp.com
Newmont Investors Should Have Expected It
fool.com
Crypto News: Pepeto Presale Advancement Update Whilst Bitcoin Price Prediction Might Reach $100,000 Soon
globenewswire.com
ROSEN, A LEADING LAW FIRM, Encourages Upstart Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UPST
newsfilecorp.com
About
as of august 7, 2019, option care and bioscrip have merged to become one national team, solely dedicated to infusion care. option care health, inc. is the largest independent home and alternate site infusion services provider in the united states. with over 6,000 teammates including 2,900 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. through our clinical leadership, expertise and national scale, option care health is reimagining the infusion care experience for patients, customers and employees.
Industry
Home Health Care Services
CEO
John Rademacher
Website
Jill D. RhodesSenior Vice President & Chief Information Security Officer
Meenal Anil SethnaExecutive Vice President & Chief Financial Officer
John Charles RademacherChief Executive Officer, President & Director
Peers— Health Care(7 companies)
Screen sector →| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
OPCH◀ | $20.03 | -1.48% | $3.1B | 15.2 | +1303.1% | 367.4% | 1500 |
| $68.56 | -3.59% | $13.3B | — | +12626.1% | -14525.8% | 1500 | |
| $513.72 | -0.71% | $11.8B | — | +43205.3% | -3008.0% | 1500 | |
| $87.60 | +0.60% | $11.5B | — | +3288.2% | -4239.0% | 1500 | |
| $183.72 | -1.59% | $10.7B | 29.2 | +1871.5% | 680.1% | 1500 | |
| $206.53 | -0.59% | $10.6B | — | +6554.5% | -2868.8% | 1500 | |
| $74.81 | +1.81% | $10.5B | 51.8 | +2325815.3% | -19.7% | 1500 | |
| Sector avg | — | -0.79% | — | 32.1 | +342094.9% | -3373.4% | 1500 |